Megestrol acetate and Cough aggravated - a phase IV clinical study of FDA data
Cough aggravated is found among people who take Megestrol acetate, especially for people who are female, 60+ old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Megestrol acetate and have Cough aggravated. It is created by eHealthMe based on reports of 4,770 people who have side effects when taking Megestrol acetate from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
4,770 people reported to have side effects when taking Megestrol acetate.
Among them, 108 people (2.26%) have Cough aggravated.
What is Megestrol acetate?
Megestrol acetate has active ingredients of megestrol acetate. It is often used in appetite - decreased. eHealthMe is studying from 4,834 Megestrol acetate users for its effectiveness, alternative drugs and more.
What is Cough aggravated?
Cough aggravated (worse cough) is found to be associated with 2,010 drugs and 804 conditions by eHealthMe.
Number of Megestrol acetate and Cough aggravated reports submitted per year:
Time on Megestrol acetate when people have Cough aggravated *:
Gender of people who have Cough aggravated when taking Megestrol acetate*:
Age of people who have Cough aggravated when taking Megestrol acetate *:
Common drugs people take besides Megestrol acetate *:
Common side effects people have besides Cough aggravated *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Megestrol acetate and have Cough aggravated?Check whether Cough aggravated is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Cough aggravated and when was it recovered:
Expand to all the drugs that have ingredients of megestrol acetate:
Alternative drugs to, pros and cons of Megestrol acetate:
- Megestrol acetate (4,834 reports)
Common Megestrol acetate side effects:
- Fatigue (feeling of tiredness): 581 reports
- Weakness: 534 reports
- Diarrhea: 476 reports
- Death: 443 reports
- Pain: 440 reports
- Pneumonia: 418 reports
- Breathing difficulty: 386 reports
Browse all side effects of Megestrol acetate:a b c d e f g h i j k l m n o p q r s t u v w x y z
Cough aggravated treatments and more:
- Cough aggravated (279 reports)
COVID vaccines that are related to Cough aggravated:
- Cough aggravated in Moderna COVID Vaccine
- Cough aggravated in Pfizer BioNTech Covid Vaccine
- Cough aggravated in Johnson and Johnson Covid Vaccine
Common drugs associated with Cough aggravated:
- Prednisone: 22,835 reports
- Methotrexate: 14,299 reports
- Enbrel: 14,161 reports
- Aspirin: 12,792 reports
- Humira: 12,752 reports
- Spiriva: 9,912 reports
- Symbicort: 9,475 reports
- Omeprazole: 8,433 reports
- Lisinopril: 8,359 reports
- Amlodipine: 7,730 reports
All the drugs that are associated with Cough aggravated:
- Cough aggravated (2,010 drugs)
Common conditions associated with Cough aggravated:
- Rheumatoid arthritis: 24,445 reports
- Asthma: 22,949 reports
- High blood pressure: 14,377 reports
- Multiple sclerosis: 8,387 reports
All the conditions that are associated with Cough aggravated:
- Cough aggravated (804 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on megestrol acetate (the active ingredients of Megestrol acetate) and Megestrol acetate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Cytarabine and Leukaemoid Reaction - now
- Cytarabine and Left Ventricular Hypertrophy - 3 seconds ago
- Cymbalta and Uterine Prolapse - 7 seconds ago
- Allegra and Suicide Attempt - 8 seconds ago
- Cyclophosphamide and Rhonchi - 8 seconds ago
- Cyclosporine and Drug Resistance - 10 seconds ago
- Cyclophosphamide and Peripheral Motor Neuropathy - 14 seconds ago
- Cytoxan and Hepatic Mass - 22 seconds ago
- Cabometyx and Drug Effect Decreased - 26 seconds ago
- Lasix and Breast Engorgement - 28 seconds ago